Your browser doesn't support javascript.
loading
SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron.
Laurie, Matthew T; Liu, Jamin; Sunshine, Sara; Peng, James; Black, Douglas; Mitchell, Anthea M; Mann, Sabrina A; Pilarowski, Genay; Zorn, Kelsey C; Rubio, Luis; Bravo, Sara; Marquez, Carina; Sabatino, Joseph J; Mittl, Kristen; Petersen, Maya; Havlir, Diane; DeRisi, Joseph.
Afiliação
  • Laurie MT; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
  • Liu J; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
  • Sunshine S; University of California Berkeley-University of California San Francisco Graduate Program in Bioengineering, Berkeley, California, USA.
  • Peng J; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
  • Black D; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Mitchell AM; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Mann SA; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
  • Pilarowski G; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Zorn KC; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
  • Rubio L; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Bravo S; The Public Health Company, Oakland, California, USA.
  • Marquez C; Unidos en Salud, San Francisco, California, USA.
  • Sabatino JJ; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
  • Mittl K; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Petersen M; Unidos en Salud, San Francisco, California, USA.
  • Havlir D; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • DeRisi J; Weill Institute for Neurosciences, Department of Neurology, San Francisco, California, USA.
J Infect Dis ; 225(11): 1909-1914, 2022 06 01.
Article em En | MEDLINE | ID: mdl-34979030
ABSTRACT
The wide spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with phenotypes impacting transmission and antibody sensitivity necessitates investigation of immune responses to different spike protein versions. Here, we compare neutralization of variants of concern, including B.1.617.2 (delta) and B.1.1.529 (omicron), in sera from individuals exposed to variant infection, vaccination, or both. We demonstrate that neutralizing antibody responses are strongest against variants sharing certain spike mutations with the immunizing exposure, and exposure to multiple spike variants increases breadth of variant cross-neutralization. These findings contribute to understanding relationships between exposures and antibody responses and may inform booster vaccination strategies.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos